Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models.
Schneider MA, Heeb L, Beffinger MM, Pantelyushin S, Linecker M, Roth L, Lehmann K, Ungethüm U, Kobold S, Graf R, van den Broek M, Vom Berg J, Gupta A, Clavien PA. Schneider MA, et al. Among authors: van den broek m. Sci Transl Med. 2021 Sep 15;13(611):eabc8188. doi: 10.1126/scitranslmed.abc8188. Epub 2021 Sep 15. Sci Transl Med. 2021. PMID: 34524861
Radiotherapy supports protective tumor-specific immunity.
Gupta A, Sharma A, von Boehmer L, Surace L, Knuth A, van den Broek M. Gupta A, et al. Among authors: van den broek m. Oncoimmunology. 2012 Dec 1;1(9):1610-1611. doi: 10.4161/onci.21478. Oncoimmunology. 2012. PMID: 23264910 Free PMC article.
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.
Gupta A, Nuber N, Esslinger C, Wittenbrink M, Treder M, Landshammer A, Noguchi T, Kelly M, Gnjatic S, Ritter E, von Boehmer L, Nishikawa H, Shiku H, Old L, Ritter G, Knuth A, van den Broek M. Gupta A, et al. Among authors: van den broek m. Cancer Immun. 2013;13:3. Epub 2013 Jan 15. Cancer Immun. 2013. PMID: 23390374 Free PMC article.
Radiotherapy supports tumor-specific immunity by acute inflammation.
Surace L, Scheifinger NA, Gupta A, van den Broek M. Surace L, et al. Among authors: van den broek m. Oncoimmunology. 2015 Jun 24;5(1):e1060391. doi: 10.1080/2162402X.2015.1060391. eCollection 2016. Oncoimmunology. 2015. PMID: 26942071 Free PMC article.
CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.
Beffinger M, Tallón de Lara P, Tugues S, Vermeer M, Montagnolo Y, Ohs I, Cecconi V, Lucchiari G, Gagliardi A, Misljencevic N, Sutton J, Spörri R, Becher B, Gupta A, van den Broek M. Beffinger M, et al. Among authors: van den broek m. JCI Insight. 2018 May 17;3(10):e97792. doi: 10.1172/jci.insight.97792. eCollection 2018 May 17. JCI Insight. 2018. PMID: 29769439 Free PMC article.
Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis.
Ducimetière L, Lucchiari G, Litscher G, Nater M, Heeb L, Nuñez NG, Wyss L, Burri D, Vermeer M, Gschwend J, Moor AE, Becher B, van den Broek M, Tugues S. Ducimetière L, et al. Among authors: van den broek m. Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):e2026271118. doi: 10.1073/pnas.2026271118. Proc Natl Acad Sci U S A. 2021. PMID: 34183415 Free PMC article.
427 results